Simplex Trading
TARS icon

Simplex Trading’s Tarsus Pharmaceuticals TARS Stock Holding History

Simplex Trading’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$59.5K Sell
946
-1,519
-62% -$97K ﹤0.01% 6126
2026
Q1 		$173K Sell
2,465
-548
-18% -$38.3K ﹤0.01% 4471
2025
Q4 		$247K Buy
3,013
+1,419
+89% +$106K ﹤0.01% 4014
2025
Q3 		$94K Buy
+1,594
New +$78.5K ﹤0.01% 5825
2024
Q2 		– Sell
-16,166
Closed -$544K – 9798
2024
Q1 		$587K Buy
16,166
+8,248
+104% +$243K ﹤0.01% 3686
2023
Q4 		$160K Buy
+7,918
New +$132K ﹤0.01% 4898
2023
Q3 		– Sell
-5,383
Closed -$95.3K – 9794
2023
Q2 		$97K Buy
+5,383
New +$85.6K ﹤0.01% 5126

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Simplex Trading's TARS Position: Q2 2026 in Review

Simplex Trading reduced its Tarsus Pharmaceuticals (TARS) stake by 62% in Q2 2026, selling an estimated $97K and leaving 946 shares worth $59.5K. The position accounts for ﹤0.01% of the portfolio, ranked #6126.

Simplex Trading first reported a position in TARS in Q2 2023 and has held it in 7 quarters since. The position peaked at $587K in Q1 2024. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • Simplex Trading held 946 shares of Tarsus Pharmaceuticals worth $59.5K as of Q2 2026.
  • Simplex Trading sold 1,519 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $97K.
  • Tarsus Pharmaceuticals made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #6126 holding.
  • Simplex Trading first reported a position in Tarsus Pharmaceuticals in Q2 2023 and has held it in 7 quarters since.
  • Simplex Trading's Tarsus Pharmaceuticals position peaked at $587K in Q1 2024.
  • 257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.